Literature DB >> 12966622

Effects of high dose IV pamidronate on disease activity and bone metabolism in patients with active RA: a randomized, double-blind, placebo-controlled trial.

Mariette C Lodder, Philomine A Van Pelt, Willem F Lems, Piet J Kostense, Cees H W Koks, Ben A C Dijkmans.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12966622

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  6 in total

Review 1.  Advances in osteoclast biology reveal potential new drug targets and new roles for osteoclasts.

Authors:  Brendan F Boyce
Journal:  J Bone Miner Res       Date:  2013-04       Impact factor: 6.741

Review 2.  Current Treatments and New Developments in the Management of Glucocorticoid-induced Osteoporosis.

Authors:  Hennie G Raterman; Irene E M Bultink; Willem F Lems
Journal:  Drugs       Date:  2019-07       Impact factor: 9.546

3.  Emerging ideas: can erythromycin reduce the risk of aseptic loosening?

Authors:  Weiping Ren; David C Markel
Journal:  Clin Orthop Relat Res       Date:  2011-05-17       Impact factor: 4.176

Review 4.  Osteoclasts have multiple roles in bone in addition to bone resorption.

Authors:  Brendan F Boyce; Zhenqiang Yao; Lianping Xing
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 5.  Osteoimmunology and osteoporosis.

Authors:  Piet Geusens; Willem F Lems
Journal:  Arthritis Res Ther       Date:  2011-09-30       Impact factor: 5.156

Review 6.  Emerging treatments for postmenopausal osteoporosis - focus on denosumab.

Authors:  Piet Geusens
Journal:  Clin Interv Aging       Date:  2009-06-09       Impact factor: 4.458
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.